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Abstract 
  
Objective Results of endovascular repair vary according to the arterial bed. We 
hypothesized that these differences may be related to the plaque features. To 
explore this hypothesis, we designed a prospective study that compared carotid and 
femoral atheroma.  
Methods and Results Patients that underwent femoral or carotid endarterectomy 
were included in our study. Demographic data and blood sampling were obtained 
prior to surgery. Plaques were evaluated for AHA grading, calcification and lipid 
content. Eighty eight plaques were harvested during this study (45 carotid specimens 
and 43 femoral specimens). No differences were noted between carotid and femoral 
groups regarding demographic and biological data. Histological data more frequently 
showed fibrous cap atheroma in carotid arteries (75%) and fibrocalcific plaques in 
femoral arteries (93%), p<0.001. Morphological analyses showed a high prevalence 
of osteoid metaplasia in femoral arteries (63 %) compared to carotid arteries (20%, 
p<0.001). Biochemical analyses were consistent with histological data, showing 
higher calcium and lesser cholesterol concentrations in femoral than in carotid 
plaques (p<0.01). 
Conclusions Femoral and carotid plaques showed different morphology in 
comparable groups of patients.  
Keys words: peripheral artery disease, atherosclerosis, vascular calcification, lipids 
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Introduction 
The definition of peripheral arterial disease (PAD) broadens towards a diverse 
group of disorders that lead to narrowing of supra-aortic trunks, aorta, upper and 
lower extremities arteries, and visceral arteries. PAD is a highly prevalent public 
health problem and is related to atherosclerosis. PAD has been classified as a 
coronary artery disease equivalent, meaning that patients with a diagnosis of PAD 
carry a risk for major coronary events equal to established coronary artery disease.1 
Given the high prevalence of coronary disease, research has focused for a long time 
on coronary arteries and little is known about the specificities of PAD. 
Currently, more and more studies show different results after endovascular treatment 
of PAD according to the arterial bed. For instance, in-stent restenosis rates differ 
according to the arterial bed. In-stent restenosis following carotid stenting is reported 
to occur in less than 10% of cases2, whereas it occurs in up to 40% of superficial 
femoral artery cases.3 In-stent restenosis following coronary stenting is reported to be 
in the range of 10% to 15%.4 However, stenting of lower extremities arteries is not as 
effective as stenting of coronary arteries since high rates of restenosis are observed 
in the range of 30% to 50%.5 Moreover, the efficacy of drug eluting stents (DES) 
differs according to the arterial bed. In 2001, Morice et al. reported 0% of coronay in-
stent restenosis at 9 months.6 For peripheral arteries, DES have not shown to 
decrease in-stent retenosis in comparison to bare metal stents.7 
Even if numerous factors such as the haemodynamic factors, the length of the lesion, 
the run-off could alter the restenosis rate, some studies have shown that the nature 
of the atheromatous plaque could be also a crucial factor of in-stent restenosis.8, 9 
For example, different studies have observed by intravascular ultrasound that soft 
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atheromatous plaques are associated with a higher risk of in-stent restenosis.10 
However, these studies did not identify the components of the plaque. Few studies 
have characterized atheromatous plaques according to the arterial bed. Some 
studies used non-invasive arterial assessment to evaluate calcification according to 
the arterial bed. CT scan for arterial calcium assessment is a non-invasive way of 
obtaining information about the presence, location and extent of calcified plaques in 
the arteries.11, 12 These studies have shown that calcification increases in older 
patients and varies according to each arterial bed. Furthermore, histopathological 
studies have noted the presence of osteoid metaplasia in a range of 9% to 13% of 
carotid plaques.13 
To our knowledge, no previous study has compared advanced atherosclerotic lesions 
between different types of peripheral arteries. This study was designed to test the 
hypothesis of the existence of heterogeneity of atheroma expression among 
peripheral arteries such as carotid and femoral arteries.  
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Materials and methods 
Patients  
From February 2008 to June 2009, atheromatous plaques were harvested from 
patients undergoing carotid or femoral endarterectomy at the department of vascular 
surgery of the Nantes University Hospital. Patients suffering from non-atherosclerotic 
peripheral arterial disease, thrombosis or restenosis, and patients who could not give 
their written consent were excluded. Demographic and clinical data were collected, 
including age, gender, treatment, cardiovascular risk factors, the presence of 
coronary artery disease or renal failure was documented. Prior to surgery, blood 
specimens were collected for  lipid balance and phospho-calcic metabolism. Sample 
collection and handling was performed in accordance with the guidelines of the 
Medical and Ethical Committee in Nantes, France, and a written informed consent 
was requested for each patient. 
Tissue sampling 
Endarteriectomies were performed on a consecutive series of patients using 
conventional surgical techniques. The plaque was removed at the bifurcation from 
within the lumen as a single specimen. All plaques were divided into 4 equal parallel 
sections. One part was processed for histological analysis, one section for scanning 
electron microscopy, and the last sections for lipid and calcium quantitative 
measurements. 
Histology processing 
Atherosclerotic plaques were immediately fixed in 10% formalin overnight and 
decalcified in Sakura TDE 30 fluid during 24 hours. They were embedded in paraffin. 
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Sections (4µm thickness) were stained with hematoxylin eosin (HE) added with 
safran. Lipid staining was obtained with Oil Red O for esterified lipids and filipin 
(filipin complex, F9765, Sigma-Aldrich, Poole, UK) for non-esterified lipids on frozen 
sections of 4µm as described by Kruth.14 
Histological grade of the atherosclerotic plaque  
The sections were graded according to a slightly modified AHA classification.15 
Modified AHA classificiation is based on the 9 categories, of which 6 correspond to 
atheromatous  plaques, type IX specimen (occlusion) were excluded from the study. 
Briefly these categories include fibrous cap atheroma (type IV), fibrous cap atheroma 
associated with fibrosis (type V), fibrocalcific plaque with more than 50% of plaque 
area calcified (type VII), fibrocalcific plaque that is mainly fibrous without a lipid core 
(type VIII). Complicated plaques (type VI) weren’t taken into account since we were 
interested by rating the underlying plaque. 15, 16 Inflammatory status of the plaque 
was determined semi quantitatively by the average number of macrophages stained 
by CD68 per mm2 in the most representative part of the plaque and the percentage of 
CD68 stained area within the entire plaque.  
Immunochemistry 
Immunohistochemistry was performed on adjacent deparaffinized sections. Sections 
were incubated with 3% hydrogen peroxide to block endogenous peroxidase and the 
non specific bindings were blocked in 4% bovine serum albumin. Monoclonal 
antibodies directed against (1) CD68, a marker of macrophages (dilution 1/60; 2165 
Immunotech, Marseille France); (2) CD31, a marker of endothelial cells (dilution 1/20; 
M823, Dako Ltd, Ely, UK); (3) smooth muscle-actin (prediluted, A2547,Sigma-Aldrich, 
Saint-Quentin Fallavier, France). Biotinylated polyclonal anti-mouse secondary 
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antibody and peroxidase-conjugated streptavidin were applied for 1 hour each with 
the use of the extravidine peroxidase for 30 min and then revealed with an AEC 
staining kit (Sigma Aldrich). Preparations were counterstained with HE. A negative 
control was analyzed using a similar procedure excluding the primary antibody.  
 
Quantitative measurements of calcium and lipids within the plaque 
Exact amounts of tissue samples, 30 to 50 mg each, were carefully weighted, 5-α 
cholestane added for internal marker, homogenized with chloroform/methanol (2:1), 
and the homogenate was extracted two times with the mixture. The extract was 
evaporated and was saponified 1h at 70°C. Sterols were extracted with cyclohexane. 
After evaporation, sterol fractions were silylated. Cholesterol was quantitated with 
gas chromatography-mass spectrometry (GC-MS). The values are given as mg/g of 
tissue. For analysis of calcium, 50 samples were first dehydrated. After carbonization 
(550°C, 12 hours) ashes were dissolved in 1 ml of nitric acid and then 24 ml of 1% 
lanthanum oxide (LaCl3). Calcium absorbance was then determined by atomic 
absorption spectroscopy at 422.7 nm using a calcium lamp (Unicam Solaar 989 
Atomic Absorption Spectrometer, Cambridge, UK) and compared to a standard curve 
constructed using known dilutions of a solution of 1000 µg/ml Ca in 1% LaCl3. 
Quantitative measurements were expressed in milligrams for gram of dried tissue. 
For some samples the length of the arterial segment available was not sufficient to 
perform all analyses, such specimens did not represent specific subgroup analysis. 
Scanning electron microscopy (SEM) 
GMA-embedded plaques (10 carotid and 8 femoral specimens) were polished with 
graded silicon carbide grinding paper (Struers Denmark) and then gold-palladium-
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coated on a Desk III (Denton Vacuum, Moorestown, USA). SEM studies were 
performed with backscattered electrons (Leo 1450 VP, Zeiss, Oberkochen, 
Germany). Phospho-calcic ratios were determined by energy dispersive system X ray 
analysis (Inca Oxford instrument, UK).  
Statistical analysis 
Statistical analysis was performed using SPSS 10.0 software. Comparison of the 
data was assessed by either the Chi Square test or the two-sample Student’s t-test. 
For phospho-calcic ratio analysis, non-parametric the Mann and Whitney test was 
used. P< 0.05 was considered significant. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 10 
 
Results  
 
Baseline characteristics 
Eighty eight patients were enrolled in the study; 45 underwent carotid 
endarteriectomy (mean age 69.7 ± 1.65 years, range 36-84) and 43 underwent 
femoral endarteriectomy  (mean age 69.2 ± 1.5 years, range 59-85). In carotid 
endarteriectomy specimens, 7 and 38 patients were respectively symptomatic and 
asymptomatic. The clinical presentation of symptomatic patients was detailed in table 
1.  A comparison of baseline clinical and biological preoperative data is shown in 
table 2. There was no significant difference between the two groups in terms of age, 
gender, cardiovascular risk factors, coronaropathy disease, renal failure, statins, 
antiplatelet therapies and vitamin K antagonists (p=NS). Lipid and phosphocalcic 
parameters were similar in both groups of patients, regardless of vitamin D level, 
which was lower in patients with femoral endarteriectomy (p<0.05).  
 
AHA specimen classification 
The histological analysis according to AHA modified classification for human femoral 
and carotid plaques is shown in Figure 1.  Seventy five percent of carotid plaques 
were classified as fibrous cap atheroma (types IV and V) versus 7% of the femoral 
plaques (p<0.001). On the other hand, 93% of femoral plaques were classified as 
fibrocalcific plaques (types VII and VIII) versus 25% of carotid plaques (p<0.001).  
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Femoral and carotid plaques display different mineral patterns 
Sampling of human atherosclerotic plaques from patients undergoing carotid or 
femoral endarteriectomy indicated the presence of 4 types of calcifications: sheetlike 
calcification, nodular calcification, clear centre calcification and osteoid metaplasia. 
Sheetlike calcification was defined as a calcification front within fibrosis, surrounded 
by numerous calcified micronodules (Figure 2A and 2E). Nodular calcification was 
characterized by numerous stratified deposits of calcification with multinodular edges, 
consistent with an aggregation phenomenon, and the presence of very few cells 
(Figure 2B and 2F). Clear centre calcification consisted of vesicle- like structure 
outlined with calcium deposits (Figure 2C and 2G). The last type of calcification was 
osteoid metaplasia that consisted of mature bone with typical lamellar structure and 
often bone marrow (Figure 2D and 2H). The prevalence of each type of calcification 
was compared (Figure 3A). Femoral plaques exhibited significantly more sheetlike 
calcification (86% vs 62%; p<0.05) and nodular calcification (84% vs 58%, p<0.01) 
when compared to carotid plaques. The clear centre calcification prevalence was 
similar between both specimen types. Femoral plaques more often displayed osteoid 
metaplasia (63% vs 20% p <0.001) when compared to carotid plaques. We noticed 
that osteoïd metaplasia always developed in deep regions of the intimal layer, close 
to the media and vasa vasorum (data not shown). Histological analysis of sampling of 
femoral and carotid plaques did not indicate higher density of calcium in the outer 
part of the media. Twenty seven carotid specimens and 23 femoral specimens were 
analyzed to determine the calcium level within the plaque. Femoral plaques 
displayed significantly higher amounts of calcium (194±33 mg/g vs 85±16.2 mg/g; 
p<0.01) as compared to carotid plaques (Figure 3B). The phospho-calcic atomic ratio 
determined by SEM was similar in carotid (1.89 ± 0.05) and femoral plaques (1.85 ± 
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0.34), p=0.11. These results are consistent with the presence of hydroxyapatite 
cristal. 
CD31 and smooth muscle-actin immunostaining were not different between 
atherosclerotic plaques from patients undergoing carotid or femoral endarteriectomy. 
 
 
Carotid plaques display more lipid and inflammation patterns than femoral 
plaques 
We observed intra- and extracellular lipid deposits within the plaque. Non esterified 
cholesterol was found within the macrophages (Figure 4 A). Results for quantitative 
analyses are shown in Figure 4B. Total cholesterol values differed significantly 
between carotid and femoral plaques. Mean cholesterol levels were higher in carotid 
plaques compared to femoral plaques (39.85±5.6 mg/g vs. 10.5±1.79 mg/g; 
p<0.001). Concerning the distribution of inflammatory cells, twenty carotid and 
femoral specimen were analyzed. The mean total percentage of macrophage area 
was 15.2±3.14% within carotid plaques versus 6.13±2.2% within femoral plaques 
(p<0.05) (Figure 5A). Carotid plaques (figure 5C) showed a higher content of CD68 
positive cells in relation to the total section area than femoral plaques (figure 5D): 
310.5 ± 49.15 versus 174.5 ± 39.75 / mm², p<0.05, (Figure 5B). 
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Discussion 
 
In this study we have observed that, in comparable groups of patients, femoral and 
carotid plaques showed different morphology. Indeed, carotid arteries displayed more 
lipid and inflammatory content than femoral arteries while femoral arteries were more 
prone to calcify and to develop osteoïd metaplasia. 
Site specificity for atherosclerosis is largely described. Numerous factors could 
influence regionally distinct atherosclerotic lesion development and therefore  
morphology of atheromatous plaques. Site-selectivity of atherosclerotic lesions 
includes differences in hemodynamics, the underlying wall structure, cardio-vascular 
risk factors and cellular or biochemical parameters of the arterial wall. Site-specific 
arterial wall structure could have a potential influence. However, carotid and femoral 
artery bifurcations are both considered as a transitional zone between elastic and 
muscular artery types without striking arterial geometry differences.17 Regarding 
blood flow patterns, this varies in different regions in quantitative detail and these 
variations could have a complex effect on the development of atherosclerosis. For 
example, peak/mean wall shear rates are higher in carotid arteries than in femoral 
artery.18 Blood flow variations may influence the relative residence time of 
lipoproteins, blood borne molecules and inflammatory cells that come in contact with 
the endothelial cells in each of these regions.19 On the other hand, the hemodynamic 
patterns may prime the gene expression profile of endothelial cells in subtle different 
ways so that these cells react differently to cardiovascular risk factors.20 Like 
coronary artery lesions, PAD is influenced by cardio-vascular risk factors. For 
instance, Baumgartner et al. have described a different distribution pattern of lower 
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limb atherosclerosis according to the cardiovascular risk factor profile of patients with 
peripheral arterial occlusive disease.21 Risk factor profiles for each vascular territory 
are different insofar as there is some evidence of a stronger association between 
large vessel disease and smoking and dyslipidemia, whereas diabetes appears more 
specific for small vessel disease. In their study, patterns of plaques were not 
described. Different studies have already reported cellular or biochemical variations 
in the arterial wall. To test the hypothesis of intrinsic differences in the artery wall, 
Haimovici et al. used aortic homograft transplantation to examine the responses of 
different aortic segments to a high fat atherogenic diet. Aortic segments in dogs from 
atherosclerosis-resistant thoracic aorta were transplanted into atherosclerosis-
susceptible abdominal aorta and vice versa. After 1 year, the authors observed that 
atherosclerosis-resistant segments transplanted into atherosclerosis-prone positions 
in the abdominal aorta remained lesion free even though abdominal aorta flanking 
the transplanted thoracic segment developed severe aortic atherosclerosis. In the 
same animals, atherosclerosis-prone segments transplanted into atherosclerosis-
resistant positions still developed severe aortic atherosclerosis even though the 
flanking thoracic aorta was lesion-free.22 The diversity of the origins of vascular cells 
could provide explanations about how blood vessels differ from one another and why 
they respond in disparate ways to common risk factors associated with vascular 
disease. Indeed, Majesky emphasizes that smooth muscle cell arise from distinct 
sources of progenitors, each with its own unique lineage and developmental history 
and consequently participate to the vascular bed–specific patterns of 
atherosclerosis.23 
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In the present study, the calcium content was higher in femoral plaques than in 
carotid plaques although the phospho-calcic atomic ratio was similar between both 
types of plaques. There is no evidence for higher prevalence of Monckeberg’s 
disease in femoral versus carotid specimens in our study. Nevertheless, 
Mönckeberg's sclerosis is common in peripheral artery it could be difficult to 
distinguish Monckeberg’s lesions from advanced atherosclerotic lesions.24 CT scan 
for arterial calcium is a non-invasive tool for obtaining information about the 
presence, location and extent of calcified plaques in the arteries.11 The findings on 
CT scans are expressed as a calcium score. These studies have shown that 
calcification varies according to each arterial bed. For example, calcium scoring was 
higher in iliac arteries than in carotid arteries. Differences in the content of calcium 
according to the arterial region is consistent with the histological grading that showed 
that femoral plaques are classified as fibrocalcific (VII and VIII types) whereas carotid 
plaques are classified as fibrous cap atheroma (IV and V types). In an autopsy study, 
Dalager et al. analyzed the coronary, carotid and superficial femoral arteries from 
100 individuals.15 They clearly showed the artery related differences in phenotypic 
expression of atherosclerotic plaques. In the bifurcated carotid region most of the 
plaques were lipid core plaques (types IV and V) and more than half of femoral 
plaques were classified as fibrous type VIII lesions. In another autopsic study, 
Sawabe et al revealed that the severity of atherosclerosis differed among arteries. 
They observed that the aorta and arteries of the lower extremities were severely 
affected, while the abdominal arteries, such as the splenic and superior mesenteric 
arteries, were mildly affected.25 Initiation and rate of lesion progression should be 
taken into account to interpret the histological grading related differences. Indeed our 
analysis is confined to a single point and assumes a similar rate of atheromatous 
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disease progression in each plaque location. Moreover, Stary showed that the 
natural trend of the plaque was toward a fibrocalcific phenotype.26 According to 
Dalager et al., carotid plaques seem to be observed sooner than femoral plaques 
with a prevalence of lipid core plaques.15 Consequently, these findings suggest the 
hypothesis of different kinetics of progression of atheromatous plaques according to 
the arterial region, however to date no data are available on this matter.  
Femoral plaques exhibit significantly more sheetlike calcification, nodular calcification 
and osteoid metaplasia than carotid plaques. The most striking difference between 
both types of plaques is related to the prevalence of osteoid metaplasia in femoral 
plaques. Up to date, different studies reported the presence of both cartilaginous and 
bone formation in atheromatous plaques but few studies reported prevalence of 
osteoid metaplasia in peripheral arteries.13, 27, 28 In carotid arteries, the prevalence of 
ossification was evaluated approximatively between 9% to 13%. 13, 28 These data are 
consistent with our own results. The origin of this pathological change has been 
attributed to metaplastic osteogenesis along an endochondral pathway.29 Although 
we have punctually found cartilage tissue in our specimens (data not shown), 
membranous ossification could not be excluded. In membranous ossification bone is 
built via the differentiation of mesenchymal cells in osteoblasts that product osteoid 
matrix that is further mineralized. 
We observed a significant increase of the serum level of vitamin D in the patients 
from the carotid group although all levels were clearly under normal values in both 
groups. It is clear that vitamin D could influence PAD because of its effect on target 
cells and tissues. 30 However, there is controversy concerning the action of vitamin D 
on arterial calcification in humans. Even though vitamin D promotes calcifications in 
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vitro31, in clinical studies authors reported either no effect or an inverse relationship 
between vitamin D levels and vascular calcification. 32-34 
The present study is a cross-sectional study of carotid and femoral plaques obtained 
from different patients at a single point in time. Consequently, we cannot rule out a 
bias created by harvesting carotid and femoral plaques in different patients. Indeed, 
in order to obtain a better matching, carotid and femoral plaques should be harvested 
in the same patient. Obviously, few patients require both femoral and carotid 
endarterectomy at a single point in time. Although we can only postulate that the 
observed lesions represent the late plaque lesion, further studies of plaques are 
needed with a wide range of disease severity to further define plaque morphology, 
cellular and molecular factors involved in progression from the apparent early lesion 
to clinically significant artery stenosis. Furthermore, factors such as the delay 
between symptoms onset could influence plaque type. These factors differ between 
groups and could be a limit to this study. In carotid arteries, surgery is requested for 
different degree of stenosis according the symptomatology.35 Moreover, in 
symptomatic carotids, it is recommended to undergo surgery in the 15 days following 
the onset of symptoms.35 For femoral arteries, each patient underwent conservative 
therapy combined at least for 3 months before surgical procedure but the delay prior 
to surgery differs a lot between each patient according their clinical history. 
The results of this study demonstrate that femoral and carotid plaques show different 
morphology at a single point in time. Mechanisms and clinical implications of 
atheroma plaques heterogeneity within the arterial tree should be investigated for a 
better understanding of the characteristics of the arteries and to choose the best 
medical, endovascular or surgical option to treat atheromatous lesions. 
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Figure legends 
 
Figure 1 : Histological classification of carotid and femoral plaques according to a 
slightly modified AHA classification (15). Type IV and V are defined as fibrous cap 
atheroma. Type VII and VIII are defined as fibrocalcific plaques. 
 
Figure 2: Hematoxylin eosin and safran (HES) staining and scanning electron 
microscopy (SEM) backscattered electron images. (A) HES stain, original 
magnification X200 , sheetlike calcifications. (B) HES stain, original magnification 
X200, nodular calcifications. (C) HES stain, original magnification X400, clear centre 
calcifications. (D) HES stain, original magnification X100, osteoid metaplasia. (E) 
SEM, original magnification X 1000, sheetlike calcifications (F) SEM, original 
magnification X 500, nodular calcifications (G) SEM, original magnification X 1000, 
clear centre calcifications (H) SEM, original magnification X 250, osteoid metaplasia. 
 
Figure 3: Qualitative (A) and quantitative (B, expressed as mean ± SEM)  
assessments of mineral patterns in carotid and femoral plaques.*P< 0.05, **P< 0.01, 
***P< 0.001 
 
Figure 4: (A) Lipid staining was obtained with filipin and macrophages were stained 
by a monoclonal antibody directed against CD68. (B) Quantitative measurements of 
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cholesterol within carotid and femoral plaques were expressed in milligrams per gram 
± SEM of dried tissue. **P<0.01 
 
Figure 5: Quantitative measurements of macrophages within carotid and femoral 
arteries (A,B)  * P< 0.05. C : Example of CD68 staining of a carotid specimen, 
original magnification X50. D : Example of CD68 staining of a femoral specimen, 
original magnification X50. 
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Table 1: Clinical presentation and delay to surgery of the seven symptomatic carotid 
patients. 
SYMPTOMS TYPE DELAY TO SURGERY (days) 
 
Hemiparesis infarction 147 
Aphasia and brachiofacial paresis infarction 118 
Brachiofacial paresis infarction 58 
Facial paresis infarction 40 
Amaurosis fugax transient ischemic attack 120 
Brachiofacial paresis infarction 15 
Aphasia and brachiofacial paresis infarction 15 
 
 
 
 
 
 
 
 
 
 
 
Table(s)
Table 2: Baseline characteristics, treatment and biomarkers according to 
atheromatous plaque location 
  
Carotid plaques 
(n=45) 
Femoral plaques 
(n=43) 
p 
Demographic data and medical 
History* 
   
Age, y 69,7 (± 1.65) 69,2 (± 1.5) 0.8 
Male, % (n) 71,1 (32) 86 (37) 0.12 
Hypertension, % (n) 88.9 (40)  81.4 (35) 0.32 
Diabetes, % (n) 17.8 (8) 20.9 (9) 0.71 
Hypercholesterolaemia, % (n) 82.2 (37) 83.7 (36) 0.85 
Smoking, % (n) 71.1 (32) 72.1 (31) 0.92 
Body mass index, kg/m2 26.5 (± 0.7) 26.4  (± 0.6) 0.92 
Coronaropathy, % (n) 55.6 (25) 53.5 (23) 0.85 
Renal failure, % (n)  48.9 (22) 41.9 (18) 0.51 
Medications*    
Statins, % (n) 84.4 (38) 76.7 (33) 0.36 
Vitamin K antagonists, % (n) 2.2 (1) 4 (9.3) 0.15 
Antiplatelet agents, % (n) 100 (45) 93 (40) 0.11 
Biomarkers*    
LDL-C (g/L) 1 (± 0.05) 0.94 (± 0.05) 0.36 
Vitamin D (ng/mL), 17.7 (± 1.58) 12,26 (± 1.06) 0.006 
PTH (pg/mL) 51.96 (± 4,26) 54 (± 3.55) 0.71 
Ionised calcium (mmol/L) 1.24 (± 0.01) 1.22 (± 0.01) 0.3 
 
*Clinical characteristics ‘medications’ and ‘biomarkers’ are expressed as mean±SEM 
or % (n). LDL-C = low-density lipoprotein cholesterol 
 
 
 
 
 
 
 
